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ABSTRACT
The mammalian antibody repertoire is shaped by
somatic hypermutation (SHM) and class switch
recombination (CSR) of the immunoglobulin (Ig)
loci of B lymphocytes. SHM and CSR are triggered
by non-canonical, error-prone processing of G/U
mismatches generated by activation-induced
deaminase (AID). In birds, AID does not trigger
SHM, but it triggers Ig gene conversion (GC), a
‘homeologous’ recombination process involving
the Ig variable region and proximal pseudogenes.
Because recombination fidelity is controlled by the
mismatch repair (MMR) system, we investigated
whether MMR affects GC in the chicken B cell line
DT40. We show here that Msh6/ and Pms2/
DT40 cells display cell cycle defects, including
genomic re-replication. However, although IgVk GC
tracts in MMR-deficient cells were slightly longer
than in normal cells, Ig GC frequency, donor
choice or the number of mutations per sequence
remained unaltered. The finding that the avian
MMR system, unlike that of mammals, does not
seem to contribute towards the processing of G/U
mismatches in vitro could explain why MMR is
unable to initiate Ig GC in this species, despite
initiating SHM and CSR in mammalian cells.
Moreover, as MMR does not counteract or govern
Ig GC, we report a rare example of ‘homeologous’
recombination insensitive to MMR.
INTRODUCTION
The antibody repertoire of higher organisms is ﬁrstly
generated by VDJ recombination, followed by additional
genetic modiﬁcation through somatic hypermutation
(SHM), immunoglobulin gene conversion (Ig GC) and
class switch recombination (CSR). During SHM, nucleo-
tide changes are introduced into the exons encoding the
variable (IgV), N-terminal domain of the antibody heavy
and light chains by a mechanism involving error-prone
DNA polymerases [reviewed in (1,2)]. Although Ig GC
serves the same purpose, mutations are not introduced
directly but are copied from numerous pseudogene
sequences located upstream on the same chromosome
(3,4). In contrast, CSR involves the fusion of the IgV
to a different constant (effector) region by double-strand
break-induced region-speciﬁc recombination [reviewed
in (5,6)].
SHM, Ig GC and CSR are all initiated by activation-
induced deaminase (AID) (7–9), an enzyme expressed
in antigen-stimulated B cells, which typically converts
multiple cytosines in the Ig loci into uracils (2).
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Although uracil is generally highly efﬁciently repaired by
base excision repair (BER), this process seems to be inef-
ﬁcient in antigen-stimulated B cells. Thus, some uracils
persist until the next round of replication to give rise to
C:G to T:A transition mutations (1,2). Others are removed
by uracil–DNA glycosylase (UNG) (10–12), but the result-
ing abasic sites persist and are bypassed by translesion
polymerases to yield all types of mutations at C:G base
pairs (2,13). A third group of uracils is addressed by a
poorly deﬁned pathway, which involves MutSa (11,14),
a heterodimer of mutS homologue 2 (MSH2) and MSH6
that normally initiates DNA mismatch repair (MMR)
(15,16). It was proposed that MutSa detects G/U
mismatches generated by AID and triggers an error-
prone, long-patch repair process that introduces muta-
tions at sites distal to those deaminated by AID (1,2). A
related mechanism that involves MutSa and other factors
was postulated to act at Ig switch regions to give
rise to double-strand breaks that trigger CSR in the
absence of UNG (11,17). The molecular mechanism
of MMR-mediated diversiﬁcation of Ig genes remains
to be elucidated, but genetic experiments implicated
exonuclease I (18), DNA polymerase Z (19,20) and
monoubiquitylated proliferating cell nuclear antigen
(21,22) in this process. Interestingly, MutLa, a
heterodimer of mutL homologue 1/postmeiotic segre-
gation increased S cerevisiae 2 that acts immediately
downstream of MutSa during MMR (15), plays no role
in SHM [reviewed in (1)], although it can inﬂuence
the chromosome rejoining pathway during CSR (23).
The roles of UNG and MutSa in mammalian antibody
diversiﬁcation seem to be partially redundant, given that
only their combined deﬁciency abrogates both CSR and
SHM. Thus, in Ung/ Msh2/ or Ung/ Msh6/
mice, Ig lesions are limited to C:G to T:A transitions
(11,24).
That antibody diversiﬁcation can also involve Ig GC
was ﬁrst shown in chickens (3,4), and probably contrib-
utes to antibody diversiﬁcation in most bird species (25)
and rabbits (26), and perhaps in other species (25). The
IgV exons, VJ in the light chain and VDJ in the heavy
chain, are located downstream from an array of V, VJ
and VDJ pseudogenes (referred to as cV) that serve as
donors in the gene conversion reactions. Ig GC replaces
a contiguous stretch of 8 to >200 nucleotides and can thus
introduce multiple base changes into the recipient V(D)J
sequence (27), which may translate into amino acid re-
placements affecting the speciﬁcity and/or afﬁnity of the
antibody.
The chicken DT40 B cell lymphoma line undergoes con-
stitutive AID-dependent Ig GC (28,29), and it is widely
used to study antibody diversiﬁcation (25,30,31) as well as
DNA repair (31–33). Ig GC in DT40 cells is commonly
used as a model for homologous recombination (HR)
repair because the initiating event is well deﬁned and
requires HR factors, including the RAD51 paralogues
XRCC2, XRCC3 and RAD51B (34), BRCA1 (35),
BRCA2 (36) and RAD54 (37).
Unexpectedly, MMR does not seem to initiate Ig GC
in DT40 cells, given that UNG inhibition or knockout
largely eliminated Ig GC, accumulating instead C to
T mutations (38,39). This implies that, unlike the mamma-
lian enzyme (11,24), chicken MutSa does not recognize
AID-generated G/U mismatches, that MMR-dependent
processing of G/U mispairs does not take place in this
system in the absence of UNGor thatMMR-mediated pro-
cessing of G/U mispairs in DT40 cells is mostly error-free,
as seen in a proportion ofAID-generated uracils inmouse B
cells (40). However, even ifMMRdoes not trigger IgGC, it
would be still predicted to affect its outcome; it should
restrict it by preventing recombination between sequences
that are too diverged (41–45), while, on the other hand,
helping to repair mismatches arising through annealing
of non-identical (homeologous) donor and recipient DNA
sequences (31,33,46,47). Although MSH6-, MSH4- or
MSH3-deﬁcient cells were reported to undergo IgGC [pre-
viously mentioned (7) as data not shown], the role ofMMR
in this process has not been studied in detail or compared
with HR.
In this study, we describe the effect of MutSa and
MutLa deﬁciency on the frequency, ﬁdelity and overall
quality of Ig GC in DT40 cells. Our data reveal that
MMR is largely dispensable in this process, possibly
because of its limited contribution towards processing of
AID-generated uracils at the Ig locus. Moreover, we ﬁnd
that Ig GC represents a rare case of ‘homeologous’ recom-
bination that is insensitive to the anti-recombination
effects of MMR.
MATERIALS AND METHODS
Cell lines and transfections
DT40 IgM CL18 (28) or its IgM+derivative CL18c4 (34)
was grown in 5% CO2 at 41
C in RPMI 1640 with glu-
tamine (Wisent) supplemented with 10% FCS (Wisent),
1% chicken serum (Invitrogen), 50 mM b-MSH and anti-
biotics. DT40 Aid/ was a kind gift of Dr H. Arakawa
and Dr J.M. Buerstedde (7). Transfections for gene tar-
geting and MSH6 complementation were as previously
described (10,34). Retroviral particles for DT40 transduc-
tion were produced in HEK293T cells co-transfected with
a plasmid for VSV-G, a plasmid for MLV gag/pol and the
retroviral vector pMIG or pMIG-Ugi. HEK293T super-
natant was harvested 48 h post-transfection, ﬁltered and
added to 106 DT40 cells in the presence of 8 mg/ml of
polybrene in 24-well plates.
Gene targeting
The structure of the chicken Msh6 and Pms2 genes was
determined by assembling the sequence of multiple poly-
merase chain reaction (PCR) products ampliﬁed from
DT40 genomic DNA using oligonucleotides designed to
span one or more introns based on the gene structure of
the murine genes. The oligonucleotide sequences were
based on the corresponding chicken cDNAs assembled
from multiple expression sequence tags obtained from
GeneBankTM. The structures of the genes, targeting and
screening strategies were conﬁrmed by Southern blot. The
targeting constructs were assembled in pBluescript II
(Supplementary Figure S1). Antibiotic resistance cassettes
were described earlier (48). The Msh6 targeting construct
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eliminates the last 20 amino acids encoded by exon 4 and
most of the 30-adjacent intron, including the splice donor
site, and creates a frameshift. The Pms2 targeting con-
struct eliminates exons 7 and 8 of the gene. Genomic
DNA was puriﬁed using Puregene DNA isolation kit
(Gentra) and digested with BamHI–EcoRI for screening
Msh6 targeting or BamHI–XbaI for Pms2. Probes were
labelled by PCR using 2 mM dATP/dAGT/dTTP and
50 mCi of [a-32P]dCTP and oligonucleotides OV1 (TGG
GAGCAGGTAGTTTTGTG) and OV2 (CTCTGGGAT
GTCAGCAAGTC) for Msh6 and OJ43 (TGACAGGTT
CTGCGTTCATA) and OJ44 (TAGGGCAGCATTCCA
TTC) for Pms2. Probes were puriﬁed using Illustra
MicroSpin G-50 columns (GE Healthcare), and ﬁlters
were hybridized in ExpressHyb (Clontech) and developed
by PhosphorImager (GE Heathcare).
Growth and cell cycle analysis
Growth curves were generated by diluting exponentially
growing cultures to 5–10 105 cells/ml that were kept in
the log phase by appropriate dilutions. Trypan
blue-excluded cells were periodically counted in a haemo-
cytometer and corrected for dilution factor. Population
doubling times were calculated from exponential curve
ﬁts of cell numbers versus time plots using Prism 5
(GraphPad software Inc). Cloning efﬁciency was
estimated by ﬂuorescence-activated cell sorting (FACS)-
depositing single cells into 150 ml of normal culture
medium in 96-well plates and counting the number of
viable clones per plate after 2 weeks. DNA content
proﬁles were determined by ﬂow cytometry of 2 106
cells ﬁxed in cold 70% ethanol, and stained in 0.5%
Triton X-100, 100mg/ml of RNase A and 60mg/ml
propidium iodide. S-phase proﬁles were determined by
ﬂow cytometry in cells pulsed for 30min at 37C in
medium containing 10 mM BrdU (Sigma). Cells were
ﬁxed as described earlier in the text, and DNA was
denatured in 2N HCl 0.5% Triton X100, neutralized
with 1M Na2B4O7 pH 8.5 and labelled with anti-BrdU-
ﬂuorescein isothiocyanate (FITC) antibody (BD
Biosciences) and propidium iodide. Apoptosis was
determined by Annexin V-FITC staining (Sigma). Drug
sensitivity was measured by culturing 50 000 cells for
24 h in 96-well plates in increasing concentrations of
6-thioguanine (Sigma). Viability was estimated by MTS
reduction using Celltiter 96 Aqueous non-radioactive
cell proliferation assay (Promega).
Antibody diversiﬁcation assays
For IgM phenotype ﬂuctuation analysis, homogeneous
IgM+ or IgM populations were obtained by FACS
after blocking for 10min in phosphate-buffered saline,
1% bovine serum albumin, 3% normal goat serum and
staining for 30min with anti-chicken IgM-FITC (Bethyl,
1:200). Dead cells were excluded by propidium iodide
staining (10mg/ml). Multiple 500 000 cell populations
were cultured in 24-well plates for a given number of
population doubling times, splitting 1:2 every 1 or
2 days, and their surface IgM phenotype determined by
ﬂow cytometry. Where indicated, the culture medium
was supplemented with 1.25 nM Trichostatin A (TSA)
(Sigma). Cells expressing Ugi or the control retrovirus
were selected by GFP expression and stained using
anti-chicken IgM-PE mAb (Southern biotech). Reduced
UNG activity was conﬁrmed by enzymatic assays as
described previously (10).
Sequence analysis
IgM+ or IgM cells (1–5 105) from the expanded DT40
populations were sorted by FACS, resuspended in
DirectPCR (Viagen) and extracted with proteinase K.
The variable region of the rearranged DT40  light
chain locus was PCR ampliﬁed using KOD DNA poly-
merase (Novagen) [95C 2min+8 (95C 20 s, touch
down 68 >60C 10 s, 70C 1min)+23 (95C 15 s, 60C
10 s, 70C 1min)+72C 5 min]. PCR products were
A-tailed, cloned into pGEM-T-Easy (Promega) and
sequenced by Macrogen Inc (Seoul, Korea) using the
SP6 oligonucleotide. Sequences were aligned using
Sequencher (Genecodes). Mutations were scored and
assigned to all possible donor pseudogenes using
Mutdet, a tailor-made software (D.F. and J.M.D.N., un-
published data) that assigned all possible gene conversion
events following described criteria (10,34,38). Mutdet
results were then manually veriﬁed. The pseudogene that
could explain the most consecutive mutations and had the
longest homology encompassing all mutations was scored
as the donor. The maximum gene conversion tract was
deﬁned as the longest sequence fragment sharing perfect
homology between each IgV sequence analysed and the
pseudogene explaining the most consecutive mutations.
MMR and gel-shift assays
DT40 cell extracts were prepared by lysing the cells in
isotonic lysis buffer [10 mM Tris–HCl, pH 7.5, 2mM
MgCl2, 3mM CaCl2, 0.32M sucrose, 1mM dithiothreitol,
0.1mM spermine, 0.5mM spermidine, 0.3% IGEPAL
CA-630 and complete inhibitor cocktail (Roche)]. For
gel-shift assays, 10 mg of the respective DT40 cell
extracts was incubated with 40 fmol of [32P]-labelled G/
T, G/C or+1 duplexes (generated, respectively, by anneal-
ing the oligonucleotides CCA GAC GTC TGT TGA CGT
TGG GAA GCT TGA G, CCA GAC GTC TGT CGA
CGT TGG GAA GCT TGA G or CCA GAC GTC TGT
CTG ACG TTG GGA AGC TTG A to CTC AAG CTT
CCC AAC GTC GAC AGA CGT CTG G or CCA GAC
GTC TGT CAA UGT TGG GAA GCT TGA G to CTC
AAG CTT CCC AAC GTT GAC AGA CGT CTG G, all
written 50–30) in 25mM HEPES–KOH, pH 8.0, 0.5mM
ethylenediaminetetraacetic acid, 10% (v/v) glycerol,
0.5mM dithiothreitol and 1 mg of Poly[d(I:C) d(I:C)]
for 20min at room temperature in a ﬁnal volume
of 20 ml. Samples were separated on 5 or 6% TAE–
polyacrylamide gels. The dried gels were exposed to a
PhosphorImager screens.
A detailed procedure for the MMR assays has been
described previously (49). Brieﬂy, heteroduplex DNA sub-
strates containing a G/T mismatch or a one nucleotide
insertion (+1) within a SalI restriction site, or a G/U
mispair within an AclI restriction site in the 46-bp
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polylinker of a pGEM13Zf(+) derivative, were con-
structed by primer extension, using the mismatch-
containing 31mer oligonucleotides 50-CCA GAC GTC
TGT TGA CGT TGG GAA GCT TGA G-30 for the
G/T mismatch substrate, 50-CCA GAC GTC TGT CTG
ACG TTG GGA AGC TTG A-30 for the+1 substrate or
50CCA GAC GTC TGT CAA UGT TGG GAA GCT
TGA G-30 for the G/U substrate (the mispaired or
inserted residue is highlighted in bold) and the single-
stranded phagemid DNA as template. The strand discrim-
ination signal was introduced by incubation with
N.BstNBI, which introduced a speciﬁc nick into the com-
plementary strand (30 from the mismatch) at position 350
of the duplex. Isolation of the desired supercoiled
heteroduplex substrates and the MMR assays were
carried out as described, using 100 ng (47.5 fmol)
heteroduplex DNA substrate and 80 mg of DT40 cell
extracts in a volume of 25 ml. After 45min of incubation
at 37C, the reactions were terminated by adding 10 mg of
proteinase K and heat inactivation at 55C for 2 h. After
puriﬁcation of the DNA on a Qiagen MinElute Reaction
Cleanup Kit, samples were digested with SalI and DraI or
AclI, respectively, treated with 10 mg of RNaseA overnight
and then run on a 1% TAE–agarose gel containing
0.5Gel-Red (Biotium). To inhibit BER in assays using
the G/U substrate, Thymine DNA glycosylase (TDG) was
immunodepleted as previously described (49), and the
extracts were pretreated for 10min with 4U of Ugi
(NEB) at 37C to inhibit UNG.
Statistics
Statistical analysis was performed using Prism 5
(GraphPad software Inc).
RESULTS
Growth defects in MSH6- and PMS2-deﬁcient DT40 cells
We targeted the MMR pathway in DT40 cells by disrupt-
ing either theMsh6 or Pms2 genes (Supplementary Figure
S1). Loss of MSH6 selectively depletes MutSa, which
plays an important role in both SHM and CSR, but not
MutSb, which is not involved in SHM or CSR (50–52),
but which might affect other recombinogenic events.
Similarly, loss of PMS2 depletes MutLa, which plays a
role in CSR [reviewed in (1,2,5)], but it should not affect
the other MLH1-containing heterodimer MutLg (MLH1/
MLH3), which participates in recombination (53). The
chicken MSH6 and PMS2 proteins have not been
characterized but share high similarity in primary
sequence as well as in their structural and functional
features with their mouse and human orthologues
(Supplementary Figure S2).
To our surprise, Msh6/ and Pms2/ DT40 cells dis-
played major growth defects. Both cell lines had consider-
ably longer lag phases (not shown) and a 2-fold increase
in the population doubling times during exponential
growth (Figure 1A and B). In addition, their cloning
efﬁciencies were extremely low (Figure 1C). Because
such drastic growth phenotypes have not been described
in MMR-deﬁcient cells from other organisms, we wanted
to verify that they were indeed a consequence of the MMR
deﬁciency. We, therefore, complemented the DT40
Msh6/ line with human MSH6. This largely rescued
growth and cloning efﬁciency (Figure 1A–C), which
suggests that the phenotype is indeed caused by the
MMR gene defect. The difference between wild type
(WT) and hMSH6-complemented Msh6/ cells could
be caused by sequence divergence between chicken and
human MSH6 (Supplementary Figure S2) and/or insufﬁ-
cient expression levels of the complemented cells. The
heterozyogous Msh6+/ and Pms2+/ cells displayed
only small increases in population doubling times, but
both showed reduced cloning efﬁciency, albeit to a much
lesser extent than the homozygous knockouts (Figure 1B
and C). It seemed conceivable that the observed growth
defects were related to DNA damage caused by AID.
However, as doubly deﬁcient Msh6/ Aid/ DT40
cells had similar growth defects to Msh6/ cells
(Figure 1D), this was not the case. Ablation of MSH6
or PMS2 in a second, IgM+, DT40 line CL18c4 led to
similar phenotypes and showed an IgMdull subpopulation,
which was constant over time and likely, another mani-
festation of the growth defects (Figure 1E). We, therefore,
conclude that normal DT40 growth is dependent on the
MMR pathway.
Cell cycle alterations in MSH6- and
PMS2-deﬁcient DT40
Unlike parental DT40, logarithmically growing Msh6/
and Pms2/ cells showed many Trypan blue-positive
cells indicative of necrotic cell death (data not shown).
Although we observed a trend towards higher spontan-
eous apoptosis in the Msh6/ and Pms2/ cells
(Figure 2A), this was too small to account for the
growth defects. Microscopic examination showed mor-
phologically abnormalities in the Msh6/ and Pms2/
cultures, with numerous cells larger than normal. These
cells had larger, often bi- or multilobular nuclei
(Figure 2B), which suggested cell cycle checkpoint
defects. Indeed, analysis of DNA content conﬁrmed cell
cycle alterations, with reduced proportion of cells in
S-phase and a signiﬁcant number of cells with
>4n DNA content (Figure 2C). Complementation of
Msh6/ DT40 cells with hMSH6 corrected these defects
to a large extent (Figure 2C). 2D cell cycle analysis of
Msh6/ cells using BrdU incorporation to distinguish
cells in S-phase revealed a defect in DNA damage-induced
G2/S checkpoint (Figure 2D), as previously described
for MMR-deﬁcient cells (54). More importantly, a
second cycle of replication and a distinct cell population
with 8n DNA content were visible in Msh6/ cells,
indicative of endore-duplication (Figure 2D). Thus,
MMR-deﬁciency in DT40 causes cell cycle defects and
re-replication that are most likely responsible for the
impaired growth.
MMR deﬁciency does not increase Ig gene conversion
frequency
We analysed the frequency of Ig GC to test whether
MMR counteracted this process, either through error-free
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repair of G/U mispairs or through its anti-recombination
activity. The frequency of Ig GC can be estimated from
ﬂuctuation analysis of the surface IgM phenotype in DT40
(Figure 3A) (34). In brief, multiple subclones of the IgM
DT40 CL18 cell line, which has a frameshift in IgV
preventing IgM expression (28), are expanded over time.
Reversion of the frameshift by constitutive Ig GC allows
re-expression of IgM with the median proportion of IgM+
cells in the clonal populations providing an estimation
of Ig GC frequency. As the proportion of IgM+ cells
increases with clonal expansion time, any difference
in growth kinetics would affect these assays, which
was a major concern in this case. Moreover, we could
not obtain Msh6/ or Pms2/ single-cell clones
(Figure 1C). We, therefore, modiﬁed the ﬂuctuation
assay by setting up multiple populations at exponential
growth density (0.5 106 sIgM cells/ml). These large
starting populations bypassed the defect in cloning efﬁ-
ciency and minimized the distorting effects that the
much longer lag phase in more diluted Msh6/ and
Pms2/ cultures would have on Ig GC frequency.
To account for the different growth rates, we expanded
the cell populations for the same number of generations,
which were calculated from the respective population
doubling times. We conﬁrmed that the median proportion
of IgM+cells increased linearly with the number of popu-
lation doublings for DT40 WT as well as Msh6/ cells
(Figure 3B and C). When we used this method to compare
the DT40 CL18 to multiple independent Msh6/ or
Pms2/ derivatives, we observed interclonal variability.
Nevertheless, although the median proportion of IgM+
cells arising from DT40 Msh6/ was reduced for one
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Figure 1. Impaired proliferation in MMR-deﬁcient DT40 cells. (A) Growth curves of log-phase cultures of DT40 CL18 cells, its Msh6/ derivative
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line, it was not signiﬁcantly different in three others
(Figure 3D). Similarly, one DT40 Pms2/ line generated
only few IgM+cells, but two others were signiﬁcantly dif-
ferent neither from CL18 nor from their Pms2+/ parental
lines. The variability in IgM+ proportion between lines
could not be accounted for by variations in AID levels
(Figure 3E; data not shown) nor did it correlate with
their relative population doubling times. We suspect
these variations to be because of different compensatory
adaptations arising in the MMR-deﬁcient lines during
clonal expansion and growth. Importantly, Ig GC in
Msh6/ cells proceeded through its canonical mechan-
ism. First, UNG deﬁciency caused by expressing the
protein inhibitor Ugi in two independent DT40 Msh6/
cell lines inhibited Ig GC as shown by a decrease in the
frequency of IgM+cells (Figure 3F) (38). Second, analysis
of DT40 Msh6/ Aid/ lines showed that ablation of
Msh6/ did not result in spontaneous Ig GC in the
absence of the initiating lesion even on treatment with
Trichostatin A (Figure 3G), which exacerbates Ig GC in
DT40 cells (55).
The frequency of Ig GC could be overestimated
when normalized to population doubling times, which is
inﬂuenced by cell death. Nevertheless, the BrdU pulse-
chase experiments suggest that the cell cycle is longer in
MMR-deﬁcient than in WT DT40 cells given the persist-
ence of a higher proportion of BrdU+cells inMsh6/ and
Msh6+/ cells 24 h post-pulse (Figure 2D; data not shown).
In any case, when logarithmically growing cells were
expanded for the same length of time, Ig GC was still
apparent, although its frequency in MMR-deﬁcient DT40
cells was2- to 4-fold lower than in the control population
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(e.g. compare IgGC for CL18 at 60 generations toMsh6/
1015 at 30 generations in Figure 2C; data not shown).
We conclude that MSH6 and PMS2 are dispensable for
Ig GC, and that their deﬁciency does not result in any
obvious change in Ig GC mechanism (i.e dependence on
AID and UNG). We cannot formally rule our that MSH6
and PMS2 might be required for optimal Ig GC (see later
in the text), but our results show that their absence does
not lead to an increase in Ig GC frequency.
MMR deﬁciency does not signiﬁcantly affect the outcome
Ig gene conversion
As the growth defects in MMR-deﬁcient DT40 cells
hinder accurate calculation of Ig GC frequency, we
analysed the GC events by sequencing the IgVl region
ampliﬁed from IgM+ cells. This analysis provides infor-
mation about multiple parameters that could be affected
by MMR (Supplementary Figure S3), can be unequivo-
cally scored and are less inﬂuenced by cell growth. Thus,
we analysed the GC donor pseudogene usage, GC tract
length, number of GC events per sequence and frequency
of untemplated point mutations. We compared independ-
ent (not clonally related) Ig GC events obtained from
multiple subpopulations of various DT40 lines grown
for the same number of generations.
IgGC in chickens prefers using the most similar pseudo-
gene as donor (27). The pseudogene cVL8 is most closely
related in sequence to DT40 V (90% overall, 97%
around the frameshift insertion) (Supplementary Figure
S4), and, as anticipated, it was most frequently used to
correct the frameshift in DT40 CL18 (Figure 4A). This
preference was retained in the Msh6/ or Pms2/ cells
(Figure 4A). We observed slightly longer GC tracts in
DT40 Msh6/ cells than in CL18, but this difference
was not signiﬁcant, irrespective of whether the data from
each independentMsh6/ line were analysed separately or
pooled (Figure 4B and C). A clearer trend towards longer
Ig GC tract lengths in the Pms2/ cells became statistic-
ally signiﬁcant when the analysis was restricted to Ig GC
events templated on cVL8 (Figure 4C). This eliminates
confounding effects, such as differences in the length,
relative orientation or degree of homology of different
pseudogenes with the IgV.
We then compared the number of mutagenic events per
sequence. Should MMR-deﬁcient cells be more permissive
for recombination, one would expect more GC events per
sequence. However, this was not the case (Figure 4D).
Alternatively, if MutSa was recognizing AID-generated
G/U mispairs to initiate faithful MMR, Msh6/ cells
would be expected to display more single base pair muta-
tions at the IgV. This was also not the case. The data set of
sequences obtained from IgM+ cells arising from IgM
populations had a similar ratio of point mutations per
mutated sequence in CL18 and Msh6/ or Pms2/
lines (Figure 4E). A complementary experiment analysing
mutations in the IgV of IgM-loss cells originating from the
IgM+ Msh6/ did not show any increase in mutations
either (Table 1). Combining MSH6 deﬁciency with UNG
inhibition by expressing Ugi in two independent CL18c4
Msh6/ lines increased untemplated point mutation
frequencies (Table 1), but not beyond what others and
us have observed in UNG-deﬁcient DT40 cells (38,39).
Thus, MSH6 or PMS2 deﬁciency seems to lead to a
small increase in the length of the GC tracts, but does
not affect the donor preference or the number of muta-
genic events per sequence at the IgVl locus of DT40 cells
during Ig GC.
MMR in DT40 cells is functional, and homologous
recombination is heterology sensitive
The lack of effect of MMR-deﬁciency on Ig GC or
mutation frequency was striking. We, therefore, asked
whether MMR was active in DT40 cells. We measured
their sensitivity to 6-thioguanine (6-TG), which, once
incorporated into DNA and methylated, generates
mismatches with C that cause futile MMR cycles, DNA
fragmentation and cytotoxicity (56). As anticipated, WT
DT40 cells were sensitive to 6-TG, whereas Msh6/ cells
were resistant (Figure 5A). Pms2/ cells were also more
resistant to 6-TG than WT cells, albeit to a lesser extent
than Msh6/ cells (Figure 5A). Together with the bio-
chemical evidence described later in the text, these
results show that MMR is active in DT40 cells. Despite
this, DT40 cells fail to reject Ig GC intermediates, which
must have heterologies. We, therefore, set out to test
whether HR in DT40 cells might generally tolerate heter-
ology, especially given that one of the key hallmarks of
DT40 cells is their high efﬁciency of targeted integration
(57) mediated by HR (32). To this end, we used gene tar-
geting as an assay. The Msh6 disruption construct
inactivated the ﬁrst Msh6 allele with 35% efﬁciency. We
generated a modiﬁed version of this construct containing
15 mutations within the 1764-bp-long 50-arm (Figure 5B).
This represents only 0.8% of heterology, well below the
10% divergence between Ig VL and the donor pseudo-
genes (3); yet, it was sufﬁcient to completely abolish tar-
geting (Figure 5C and D). Because of their negligible
cloning efﬁciency, we were unable to formally demon-
strate that gene targeting sensitivity to heterology in
DT40 Msh6/ and Pms2/ cells is MMR-dependent.
However, this has been well demonstrated in bacteria
(58), yeast (59) and mammalian cells (44,60,61). Thus,
our ﬁndings show that MMR is functional in DT40
cells, and that these cells tightly control the ﬁdelity of
HR in vivo, most likely through MMR.
Extracts of DT40 cells process G/U mispairs efﬁciently
but predominantly by BER
To unequivocally demonstrate that MMR is biochem-
ically active in DT40 cells and in an attempt to identify
the possible cause(s) of the lack of effect of MutSa and
MutLa loss on GC, we examined the substrate speciﬁcity
of avian MMR. We ﬁrst carried out gel-shift experi-
ments with DT40 extracts. As shown in Figure 6A,
mismatch-speciﬁc complexes were formed on incubation
of the WT extracts with oligonucleotide heteroduplexes
containing a G/T mispair or one extrahelical nucleotide
(+1). The homoduplex G/C formed only unspeciﬁc
complexes in these extracts (lane 1) (62). The fact that
only the unspeciﬁc complexes were observed in extracts
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of the Msh6/ cells (lanes 2, 3, 5, 6, 8, 9) conﬁrmed that
the cells lacked MutSa. Moreover, this result showed that
MutSb in DT40 cell extracts either does not bind the+1
substrate or is present in undetectable amounts. We failed
to detect speciﬁc complexes with the G/U substrate even
on supplementation of the extracts with Ugi. This implied
either that, unlike the human protein (63), avian MutSa
does not recognize this substrate, or that the uracil was
removed from the oligonucleotide substrate by a
glycosylase other than UNG. Pms2/ extracts contained
similar levels of MutSa to WT extracts (Supplementary
Figure S5). To conﬁrm that the binding afﬁnity was re-
ﬂected in repair efﬁciency, we carried out in vitro MMR
assays using DT40 cell extracts and a phagemid
heteroduplex containing a G/T mispair in a SalI restric-
tion site, which makes it refractory to cleavage with this
enzyme. The phagemid also contained a nick as a strand
discrimination signal 30 from the mispaired T. In this
scenario, both MutSa and MutLa are absolutely
required for successful MMR. Digestion of the unrepaired
phagemid with DraI and SalI gives rise to fragments of
2484 and 694 bp. On correction of the G/T mismatch to
G/C, the SalI site is restored, such that the 2484 fragment
is cut into fragments of 1324 and1160 bp. Repair efﬁciency
can thus be estimated from the ratio of the 2484 and 1324
(or 1160) fragments. As shown in Figure 6B, 30% of the
G/T substrate was repaired in DT40 WT extracts (lane 2).
In contrast, extracts of Pms2/ (lane 3) and Msh6/
(lane 5) cells were repair deﬁcient. The lack of activity
was not caused by poor quality of the extracts, given
that MMR could be restored by the addition of recom-
binant human MutLa or MutSa, respectively (lanes 4 and
6). Importantly, although the WT extracts addressed the
+1 substrate with similar efﬁciency to G/T (Figure 6C,
compare lanes 2 and 4), we failed to detect repair of
either substrate in extracts of Msh6/ cells (lane 5),
unless they were supplemented with recombinant MutSa
(lane 6). This conﬁrms the results of the gel-shift
experiments and implies that MutSb in DT40 extracts is
either absent, or that it does not address an insertion/
deletion loop of one extrahelical nucleotide, an intermedi-
ate arising during Ig GC, the processing of which is
required to convert IgM cells to IgM+ phenotype.
We also wanted to learn how the extracts processed a
G/U mispair. As shown in Figure 6D (lanes 2–6), this
substrate was quantitatively converted to G/C in all
three extracts. The repair efﬁciency was diminished on
TDG depletion and Ugi addition (lanes 7–11), but supple-
mentation with recombinant MutSa or MutLa failed to
increase it, which implied that MMR does not contribute
to the processing of G/U mispairs in our assay, and that
these mispairs are addressed almost exclusively—and efﬁ-
ciently—by BER. Intriguingly, the limited effect of Ugi
addition and TDG depletion suggested that the extracts
contain another efﬁcient uracil DNA glycosylase. It could
be TDG because we cannot estimate efﬁciency of its
immunodepletion by the anti-human TDG antibody
other than from the additive effect of UNG inhibition
by Ugi and TDG immunodepletion on the in vitro
MMR assay (Supplementary Figure S6), but we cannot
exclude the presence of another enzyme, such as MBD4
(64), given that DT40 cells lack SMUG1 (65).
DISCUSSION
The near absence of Ig GC in UNG-deﬁcient DT40 cells
implied that MMR does not activate an alternative
pathway of uracil processing for initiating Ig GC
(10,39). This was unexpected, given that MMR compen-
sates to a substantial extent for UNG-deﬁciency for
SHM and CSR (11,24). Moreover, Ig GC is a process of
homeologous recombination, which is believed to involve
MMR in at least two stages (Supplementary Figure S2).
To gain insights into the criteria that govern Ig GC, we
disrupted the Msh6 or Pms2 genes in DT40 cells. In this
way, we selectively inactivated two key MMR complexes,
Table 1. Mutations in CL18c4-derived Msh6/ DT40 cells sorted for IgM-loss
Msh6+/+ Msh6/
Clone CL18c4 c414 c429
Population analysed IgM IgMlow IgMlow IgMlow IgMlow
Ugia Ugi
Sequences n 83 69 24 72 24
Mutated n (%) 39 (47) 10 (14) 12 (50) 3 (4) 14 (58)
Gene conversions Independentb 15 6 2 0 1
Total 15 6 3 0 1
Per mut seqc 0.38 0.6 0.25 - 0.1
Point mutations Independentc 15 3 10 1 14
Total 16 4 12 1 15
Per mut seqc 0.4 0.4 1 0.3 1.1
Ambiguousd 8 4 2 2 2
Insertion/deletions 8 0 0 0 0
aThe endogenous UNG activity was inhibited in vivo during expansion of the populations by expressing the Ugi protein.
bIdentical events within a population were excluded to avoid recounting dynastically related events.
cAll, rather than independent, events were considered to calculate mutation load per mutated sequence.
dSingle base pair substitutions that could have been templated or untemplated.
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MutSa and MutLa, respectively, which have been
clearly implicated in mammalian antibody diversiﬁcation
(14,23,52,66,67). At the same time, the knockouts do
not affect the other MSH and MLH heterodimers
(MutSb and MutLg), which have no role in these
processes (50–52).
MMR and DT40 cell viability
MMR has not been studied in avian cells to date. The
sequence and structure of MSH6 and PMS2 are conserved
between chicken and their mammalian counterparts
(Supplementary Figure S2), and our results show that
MMR in DT40 cells is functionally similar to MMR in
other species (it confers sensitivity to 6-TG, can repair
mismatches in vitro and triggers a DNA damage-induced
G2 checkpoint). However, unlike other eukaryotic
MMR-deﬁcient cells, the growth of the Msh6/ and
Pms2/ DT40 B cells is greatly impaired. Moreover,
they display abnormal morphology, most likely linked to
spontaneous cell cycle alterations that include one round
of endore-duplication. Based on the absence of a substan-
tial increase in apoptosis and on the abnormal nuclear
morphology, we posit that the 8n MMR-deﬁcient
DT40 cells undergo mitotic catastrophe (68). This unex-
pected phenotype contrasts with the viability of Msh6/
and Pms2/ mice (43,69) and with the fact that MSH2-,
MSH3- or MSH6-deﬁcient mouse B cells proliferate nor-
mally when stimulated in vitro (50,70,71). Nonetheless,
germinal centre B lymphocytes in Msh2/ mice show
unusually high levels of genomic instability and
compromised germinal centre reaction (66,71,72).
Germinal centre B cells express low levels of p53 (73),
which may distinguish them from in vitro activated B
cells. That p53 may be implicated in this process is
underscored by the ﬁnding that p53/ Msh2/ mouse
embryo ﬁbroblasts accumulate cells with 8n DNA content
after genotoxic damage, which implies that MMR status
and G1 checkpoint abrogation affect ploidy control (74).
Given that DT40 cells do not express p53, and thus that
their G1 checkpoint is compromised (75), they may be pre-
disposed to re-replication (76), and this phenotype might
be aggravated by the relaxation of the S (77) and G2/M
(15,54) checkpoints in MMR-deﬁcient cells. Our results
thus support a role for MMR in the prevention of
re-replication in checkpoint-deﬁcient DT40 cells.
MMR and Ig gene conversion
Although Ig GC is mediated by HR factors (33,35–37),
MMR in vertebrate cells impairs this process when
sequence heterology exceeds 1% (42–44,78).
Accordingly, MSH6- or PMS2-deﬁcient cells have a
hyper-recombinogenic phenotype both in yeast and
mammals (43,78). We demonstrate here that MMR is
functional in DT40 cells (Figures 5 and 6). We, therefore,
expected to ﬁnd an effect of MMR deﬁciency on Ig GC.
Surprisingly, we found MutSa and MutLa to be largely
dispensable for Ig GC in DT40 cells. This does not mean
they do not normally play a role during Ig GC resolution.
Indeed, we detected a signiﬁcant trend towards longer GC
tracts, most notably in PMS2-deﬁcient cells, which
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clones digested with EcoRI and BamHI. The position of DNA size
markers (left), as well as the wild-type (WT) and targeted (T) frag-
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conﬁrms that MMR affects resolution of the heteroduplex
intermediates arising during Ig GC (46,47,79). But as Ig
GC can still proceed at near normal frequency in the
absence of MMR, there must be alternative ways to
resolve the GC. On the other hand, as Ig GC involves
synapses between donor cV and acceptor IgVl sequences
that are 3 to >10% divergent (3), we expected to see its
frequency increased in Msh6/ and/or Pms2/ cells.
Yet, this was not apparent in the ﬂuctuation analyses,
despite the caveat imposed by the cell growth defects of
the MMR-deﬁcient cells. Moreover, evidence of Ig GC
should have been seen by sequencing the IgV as additional
conversion events other than the one correcting the single
nucleotide frameshift, but this was also not the case. In
addition, Ig GC generally prefers to use as donor the cV
most similar to the IgV (3,27), which implies that the HR
pathway for Ig GC senses homology. As in WT cells, the
most frequently used donor pseudogene in Msh6/ and
Pms2/ DT40 cells was cV8, which is the closest
sequence homologue to DT40 IgVl. This suggests that
the MMR defect in these cells did not bring about a re-
laxation in Ig GC stringency. MutSb could compensate
for the lack of MutSa, given that it has been shown to
contribute to repressing recombination between divergent
sequences in yeast (80). However, MutSa has a much more
prominent role than MutSb in preventing recombination
in mammalian cells (43), which, combined with our
ﬁndings that MSH6-deﬁcient DT40 extracts lack the
ability to correct +1 loops, make this scenario unlikely.
Similarly, although MutLa prevents homeologous recom-
bination in yeast (78), its absence is unlikely to be
compensated for by MutLg (81), despite the fact that
the latter factor is involved in recombination control in
mammalian cells (53). Another scenario whereby MSH6-
or MMR-deﬁciency would not affect Ig GC frequency
would be if HR in DT40 cells were less sensitive to
MMR and more permissive to heterology. However, this
was also not the case, as <1% heterology dramatically
reduced gene targeting efﬁciency in these cells. That this
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Figure 6. Mismatch binding and repair in DT40 cell extracts.
(A) Gel-shift with DT40 WT cell extracts (lanes 1, 4, 7, 10 and 13),
Figure 6. Continued
cell extracts of the Msh6/ clones 1015 (lanes 2, 5, 8, 11 and 14) and
1c1 (lanes 3, 6, 9, 12 and 15). The extracts were incubated with the
indicated substrates for 20min at RT, run on a 5% TAE–polyacryl-
amide gel and exposed to a PhosphorImager screen. (B) MMR assays
with extracts of DT40 WT, Pms2/ and Msh6/ cell lines. The
extracts were incubated with a plasmid containing a G/T mismatch
in a SalI restriction site and a nick in the T strand 350 nt 30 from the
mismatch. On repair of the mispaired T, the SalI restriction site is
restored, and digestion with this enzyme gives rise to the 1324- and
1160-bp fragments in repair-proﬁcient samples. The mean inten-
sity+standard error proportion of these two product fragments over
total signal from two experiments was quantiﬁed using ImageQuant
and is plotted for each line below the gel. (C) Mismatch repair assay
performed as in (B). Extracts of DT40 WT and Msh6/ cells were
incubated with a substrate containing a single-nucleotide insertion (+1).
The G/T substrate served as a control of repair efﬁciency.
(D) Mismatch repair assay carried out as described in (B) (lanes 2–6)
or after immunodepletion of TDG and inhibition of UNG by the
addition of Ugi (lanes 7–11). The substrate used in this assay contained
a G/U mismatch in an AclI site and a nick in the U strand 350 nt
30 from the mismatch. Repair of G/U to G/C restores the AclI site,
and digestion with this enzyme gives rise to the 1516- and 1307-bp
fragments in repair-proﬁcient samples.
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was because MMR could not be formally demonstrated
owing to the technical limitations caused by the deleteri-
ous effect of MMR deﬁciency on clonal expansion of
DT40 cells. However, as anti-recombination is an evolu-
tionary conserved function of MMR (44,58–61) and we
show that MMR is active in DT40 cells, it is likely that
it controls HR in birds. HR, but not IgGC, being sensitive
to heterologies in DT40, our results indicate a key differ-
ence between the pathways leading to gene targeting and
Ig GC.
Why is the MMR system not involved in Ig GC in
DT40 cells, when it controls HR and when it triggers
SHM and CSR in mammalian cells? Our data suggest
that part of the explanation might lie in the processing
of AID-generated G/U mispairs. Puriﬁed human MutSa
binds to G/U mispairs, albeit weaker than to G/T
(63,82,83). We failed to detect a speciﬁc gel-shift with
the G/U substrates in DT40 cell extracts, even though
G/T and +1 substrates were bound efﬁciently (Figure
6A). This could mean either that chicken MutSa does
not recognize G/U, or that the uracil was removed by
glycosylases other than UNG present in the extracts,
given that addition of Ugi had no effect. In an in vitro
MMR assay, the G/U substrate was repaired extremely
efﬁciently, and Ugi addition combined with TDG deple-
tion brought about only a small reduction in efﬁciency,
but this decrease was similar in MMR-proﬁcient and
MMR-deﬁcient extracts. We, therefore, posit that the
MMR system does not address G/U mispairs in DT40
extracts, possibly because of being outcompeted by BER
factors. Should a similar situation prevail also in vivo, then
it would explain why AID-induced G/U mispairs fail to
trigger Ig GC in UNG-deﬁcient, MMR-proﬁcient cells
(38,39). Still, this ﬁnding does not explain why MMR
status does not affect Ig GC outcome in DT40 cells. It is
possible that this is related to the recombinogenic pheno-
type of DT40 cells; as MMR is required to help maintain
their genomic stability, MutSa and MutLa enzymes might
be sequestered by HR in these cells in vivo and, therefore,
unavailable to deal with GC events. Alternatively, the dif-
ference in sensitivity to heterology during gene targeting
and Ig GC may indicate that the two processes proceed
through different HR branches in DT40 cells. Our ﬁndings
suggest that the Ig GC process in DT40 cells may repre-
sent a rare example of MMR-insensitive homeologous
recombination.
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